Literature DB >> 32140926

Investigation of the therapeutic mechanism of subthreshold micropulse laser irradiation in retina.

Kazutaka Hirabayashi1, Shinji Kakihara2,3, Masaaki Tanaka2,3, Takayuki Shindo3,4, Toshinori Murata2.   

Abstract

PURPOSE: Subthreshold micropulse laser irradiation has been used for the treatment of retinal edema; however, there are few reports about the mechanism of its therapeutic effect. In this study, we compared threshold short pulse and subthreshold micropulse laser irradiation in mice and investigated their mechanism.
METHODS: Nine to 12-week-old male C57BL/6J mice were used in this study. After general anesthesia, threshold short pulse or subthreshold micropulse laser irradiation was performed on the right eye using IQ577. Enucleation was performed 24 h after the laser irradiation, and histological and gene expression analyses were carried out.
RESULTS: Coagulation spots and atrophy of the retinal pigment epithelium were observed after threshold short pulse laser irradiation but not after subthreshold micropulse laser irradiation. Twenty-four hours after laser, aquaporin (AQP) 1, 2, 7, and 11 levels were significantly elevated by 1.7- to 3-fold in the threshold short pulse laser group compared with non-treated control group. AQP 3 was increased significantly and prominently by 100-fold. VEGF-A and VEGFR2 were upregulated 1.5- and 2.3-fold, respectively. In the subthreshold micropulse laser group, AQP 3 was increased by 6-fold compared with the non-treated control group. Angiopoietin-1 and the adrenomedullin (AM) receptor CLR were decreased by 0.6-fold and 0.5-fold, respectively.
CONCLUSION: Threshold short pulse laser irradiation caused retinal damage and prominent changes in the expression of various genes. Contrarily, subthreshold micropulse laser irradiation did not induce retinal damage; it upregulated AQP 3, which might have improved retinal edema by drainage of subretinal fluid.

Entities:  

Keywords:  Aquaporin-3; Gene expression; Retinal edema; Subthreshold micropulse laser

Mesh:

Substances:

Year:  2020        PMID: 32140926     DOI: 10.1007/s00417-020-04638-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Transcriptional regulation of aquaporin-3 in human retinal pigment epithelial cells.

Authors:  Margrit Hollborn; Elke Ulbricht; Andreas Reichenbach; Peter Wiedemann; Andreas Bringmann; Leon Kohen
Journal:  Mol Biol Rep       Date:  2012-04-26       Impact factor: 2.316

2.  Activation of phospholipase A2 by Hsp70 in vitro.

Authors:  Ajay K Mahalka; Christian Code; Behnam Rezai Jahromi; Behnam Rezaijahromi; Thomas Kirkegaard; Marja Jäättelä; Paavo K J Kinnunen
Journal:  Biochim Biophys Acta       Date:  2011-06-13

3.  Development of a Novel Model of Central Retinal Vascular Occlusion and the Therapeutic Potential of the Adrenomedullin-Receptor Activity-Modifying Protein 2 System.

Authors:  Kazutaka Hirabayashi; Masaaki Tanaka; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Kun Dai; Nanqi Cui; Yangxuan Wei; Keisei Nakamura; Shiho Iida; Shuhei Matsui; Akihiro Yamauchi; Toshinori Murata; Takayuki Shindo
Journal:  Am J Pathol       Date:  2019-01-15       Impact factor: 4.307

4.  Adrenomedullin Suppresses Vascular Endothelial Growth Factor-Induced Vascular Hyperpermeability and Inflammation in Retinopathy.

Authors:  Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Kazutaka Hirabayashi; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Tian Liu; Xian Xian; Liuyu Zhai; Kun Dai; Keiya Tanimura; Teng Liu; Nanqi Cui; Akihiro Yamauchi; Toshinori Murata; Takayuki Shindo
Journal:  Am J Pathol       Date:  2017-03-17       Impact factor: 4.307

5.  Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina.

Authors:  Ianors Iandiev; Thomas Pannicke; Martin B Reichel; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Neurosci Lett       Date:  2005-11-11       Impact factor: 3.046

6.  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1984-09-15       Impact factor: 5.258

7.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

Review 8.  Diabetic Retinopathy: Vascular and Inflammatory Disease.

Authors:  F Semeraro; A Cancarini; R dell'Omo; S Rezzola; M R Romano; C Costagliola
Journal:  J Diabetes Res       Date:  2015-06-07       Impact factor: 4.011

Review 9.  A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders.

Authors:  Paula Scholz; Lebriz Altay; Sascha Fauser
Journal:  Adv Ther       Date:  2017-05-24       Impact factor: 3.845

10.  Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula.

Authors:  Daniel Lavinsky; Jenny Wang; Philip Huie; Roopa Dalal; Seung Jun Lee; Dae Yeong Lee; Daniel Palanker
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

View more
  3 in total

1.  Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study.

Authors:  Zhen Huang; Kai-Yu Deng; Yu-Meng Deng; Yan-Nian Hui; Yan-Ping Song
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 2.  Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema.

Authors:  Muhammad Z Chauhan; Peyton A Rather; Sajida M Samarah; Abdelrahman M Elhusseiny; Ahmed B Sallam
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

3.  Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.

Authors:  Michelle Prasuhn; Yoko Miura; Aysegül Tura; Felix Rommel; Vinodh Kakkassery; Svenja Sonntag; Salvatore Grisanti; Mahdy Ranjbar
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.